3260-49-9 Usage
Description
4,6-Dihydroxybenzofuran-3-one is an organic compound that serves as a key intermediate in the synthesis of various pharmaceutical compounds. It is characterized by its unique chemical structure, which features two hydroxyl groups at the 4 and 6 positions of the benzofuran-3-one ring. This structure endows it with specific properties that make it valuable in the development of therapeutic agents.
Uses
Used in Pharmaceutical Synthesis:
4,6-Dihydroxybenzofuran-3-one is used as an intermediate in the synthesis of Diosmetin 3',7-Diglucuronide-d3 (D485042), a labelled Diosmetin 3',7-Diglucuronide (D485040). 4,6-dihydroxybenzofuran-3-one is a metabolite of Diosmetin (D485000), a flavonoid that is commonly used in the treatment of chronic venous insufficiency, hemorrhoids, and related conditions. The role of 4,6-dihydroxybenzofuran-3-one in this process is to facilitate the production of these therapeutic compounds, thereby contributing to their medicinal applications.
Check Digit Verification of cas no
The CAS Registry Mumber 3260-49-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,2,6 and 0 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 3260-49:
(6*3)+(5*2)+(4*6)+(3*0)+(2*4)+(1*9)=69
69 % 10 = 9
So 3260-49-9 is a valid CAS Registry Number.
InChI:InChI=1/C8H6O4/c9-4-1-5(10)8-6(11)3-12-7(8)2-4/h1-2,9-10H,3H2
3260-49-9Relevant articles and documents
Preparation of 4,6,3',4'-tetrasubstituted aurones via aluminium oxide-catalyzed condensation
Bolek, David,Guetschow, Michael
, p. 1399 - 1403 (2007/10/03)
4,6,3',4'-Tetrasubstituted aurones were prepared by a protection- deprotection route with an alumina-catalyzed condensation of 3(2H)-benzofuranones with substituted aldehydes as the key step. Aureusidin (6) was obtained by demethylation of 4,6,3',4'-tetramethoxyaurone (5), a natural product from Cyperus capitatus. 4,6,3',4'-Tetrabenzyloxyaurone (9) was converted in a one hydrogenation-deprotection step to dihydroaureusidin (10).